Preclinical R&D
How Much of Your Last Year’s Research Budget Felt Wasted? The Hidden Cost of Experimental Inconsistencies
Sophie Lutter, Ph.D.; Andrew Chalmers, Ph.D.
Lab Thread
PAO-06-26-CL-05Jun 29, 2026
Laboratory Data
Can Lab Management Software Help Solve the Reproducibility Crisis?
Sophie Lutter, Ph.D.
Lab Thread
PAO-034-26-CL-01Apr 1, 2026
Women's Health
Sano Women’s Health Reports Positive Nonclinical EFD Safety Results for RVVC Drug Product
Sano Women's Health
PR-01-26-02Jan 7, 2026
Organoids
How Organoids Are Continuing to Transform the Path from Bench to Bedside
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-25-NI-05Oct 16, 2025
Gender Bias
Sex Differences, Gender Biases: What Are We Really Studying in Preclinical Research?
Serene Lee
Nice Insight
PAO-05-25-NI-12May 29, 2025
Sex Differences
Half the Data, Half the Science: The Cost of Ignoring Sex Differences in Preclinical Research
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-05May 15, 2025
Preclinical Data
Mozart Therapeutics Presents Compelling New Preclinical Data on MTX-201 at the 2025 Crohn's and Colitis Congress
Mozart Therapeutics
PR-02-25-NI-01Feb 7, 2025
Annual Congress
Hemab Shares Phase 2 HMB-001 Data for Glanzmann Thrombasthenia & HMB-002 Preclinical Data for Von Willebrand at EAHAD 2025
Hemab Therapeutics
PR-01-25-NI-35Feb 7, 2025
Preclinical Data
Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene for the Treatment of Hereditary Angioedema
Poseida Therapeutics
PR-10-24-NI-63Oct 25, 2024
Clinical Data
Skyhawk Therapeutics Presents Compelling Preclinical Data at the Molecular Targets and Cancer Therapeutics Symposium
Skyhawk
PR-10-24-NI-62Oct 25, 2024
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Kristen M. Eisenhauer; Mark Mintz
Charles River Laboratories
PAO-05-23-CL-03May 5, 2023
Therapeutic Candidate
CytoDyn Takes Steps towards a Brighter Future
Cyrus Arman, Ph.D.
CytoDyn
PAO-02-23-CL-04Feb 6, 2023
mRNA Manufacture
Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers
Tonia Becker
Nice Insight
PAO-10-022-CL-03Oct 25, 2022
RNA Analysis Kit Launch
RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics
SCIEX
PR-M05-22-09May 16, 2022
M&A
Incannex to Acquire APIRx Pharmaceuticals USA, LLC
Incannex Healthcare Limited
PR-M03-22-12Mar 24, 2022
COVID-19 Antiviral
Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
Model Medicines
PR-M02-22-05Feb 8, 2022
Antibodies
Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies
Twist Bioscience
PR-M11-20-022-1179Nov 24, 2020
COVID-19 Vaccine
STI-1499, a Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability to Completely Inhibit In Vitro Virus Infection in Preclinical Studies
Sorrento Therapeutics, Inc.
PR-M05-20-NI-028May 18, 2020
Obesity
Kintai Therapeutics Advances Anti-Obesity Agent After Demonstrating Sustained Weight Loss
Kintai Therapeutics
PR-M01-20-NI-039Jan 28, 2020
CAR-T Immunotherapy
Cabaletta Bio Announces Presentation of Preclinical Data Showing Specific CAAR T Activity against Anti-MuSK Expressing B Cells
Cabaletta Bio
PR-M10-19-NI-024Oct 15, 2019